Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.


Antibiotics make MRSA worse

Antibiotics could help a drug-resistant pathogen to worsen inflammation.

Methicillin-resistant Staphylococcus aureus (MRSA) resists most β-lactam antibiotics by acquiring a protein that modifies the cell wall. David Underhill, George Liu and their team at Cedars-Sinai Medical Center in Los Angeles, California, thought that this modification might also boost the production of inflammatory molecules called cytokines in the host. They exposed mouse and human immune cells to MRSA and found that the host cells made higher levels of a cytokine called IL-1β when MRSA had been grown in the presence of β-lactams. In mice, treatment with a β-lactam caused more immune cells to flood the site of an MRSA skin infection, resulting in more inflammation and larger abscesses than in MRSA-infected mice that were not treated with the antibiotic.

MRSA infections are still sometimes treated with β-lactams, but these should be used with other antibiotic classes, the authors write.

Cell Host Microbe 18, 604–612 (2015)

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Antibiotics make MRSA worse. Nature 527, 278–279 (2015).

Download citation

  • Published:

  • Issue Date:

  • DOI:


Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing